Branched-chain amino acids and risk of major depressive disorder: a Mendelian randomization and colocalization study
- PMID: 40663140
- DOI: 10.1007/s00213-025-06851-6
Branched-chain amino acids and risk of major depressive disorder: a Mendelian randomization and colocalization study
Abstract
Aims: Depression is associated with numerous metabolic pathway abnormalities, and several studies have suggested a link between depression and branched chain amino acids (BCAAs) metabolic disorders. However, the precise causality and direction remain inconclusive. Consequently, this study aims to ascertain the relationship between the risk of depression and BCAAs levels using two-sample Mendelian randomization (MR) analysis.
Materials and methods: Single nucleotide polymorphisms associated with the BCAAs were extracted from the IEU OpenGWAS. Pooled level data for major depressive disorder (MDD) was obtained from the Psychiatric Genomics Consortium. We performed genome-wide linkage disequilibrium score regression, MR analyses, and colocalization analyses using summary genome-wide association study data across European population to probe genetic causality between BCAAs and MDD.
Results: Our results showed a causal effect of MDD risk on the increasing valine levels (IVW OR = 1.043, 95% CI = 1.006-1.082, P = 0.024) and a genetic correlation between MDD and valine. However, leucine, isoleucine, and total BCAAs were not causally associated with the risk of MDD (P > 0.05). The sensitivity analyses indicated that there was no heterogeneity or horizontal pleiotropy in our findings. The linkage disequilibrium score regression demonstrated significant evidence of shared genetic architecture between MDD and valine, with the genetic correlation estimated to be 0.112 (P = 0.002). Colocalization analysis did not provide any evidence of a shared causal variant between MDD and valine.
Conclusions: It was revealed that valine metabolism may be significantly affected by depression through a two-sample MR analysis, while no significant connection was identified between other branched-chain amino acids and depression. This result provided new insights into the metabolic processes involved in depression.
Keywords: Branched-chain amino acids; Genome-wide association study; Major depressive disorder; Mendelian randomization; Valine.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: All authors declare no conflicts of interest.
Similar articles
-
Reassessing the relationship between major depressive disorder and blood lipids: a comprehensive Mendelian randomisation study.Gen Psychiatr. 2025 Jun 26;38(3):e101900. doi: 10.1136/gpsych-2024-101900. eCollection 2025. Gen Psychiatr. 2025. PMID: 40589629 Free PMC article.
-
[Multi-omics Mendelian randomization study on the causality between non-ionizing radiation and facial aging].Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025 Jun 20;41(6):594-603. doi: 10.3760/cma.j.cn501225-20240830-00320. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025. PMID: 40588408 Free PMC article. Chinese.
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2015 Nov 5;2015(11):CD004692. doi: 10.1002/14651858.CD004692.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Nov 24;11:CD004692. doi: 10.1002/14651858.CD004692.pub5. PMID: 26537796 Free PMC article. Updated.
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5. Cochrane Database Syst Rev. 2021. PMID: 34817851 Free PMC article.
-
The causal and mediated relationships between major depressive disorder (MDD), post-traumatic stress disorder (PTSD), anxiety disorders and premature mortality: Evidence from genome-wide association study.J Affect Disord. 2025 Jun 30;390:119781. doi: 10.1016/j.jad.2025.119781. Online ahead of print. J Affect Disord. 2025. PMID: 40602538
References
-
- Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, Pool R, Thesing CS, Vijfhuizen LS, Vogelzangs N et al (2020) Metabolomics profile in depression: A pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry 87(5):409–418 - PubMed
LinkOut - more resources
Full Text Sources